Lightship is making clinical trials more accessible for patients and providers to accelerate development of better therapies for all.
Lightship has raised $16.5M in total funding. The most recent round was Series C. The last funding was announced in February 2024.
Lightship's investors include Khosla Ventures, Novartis, Define Ventures, Time Ventures, ATEL Ventures.
Lightship is headquartered in El Segundo, United States.
Lightship is making clinical trials more accessible for patients and providers to accelerate development of better therapies for all.
Lightship is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lightship — Funding & Investors." VCBacked, February 12, 2024, https://www.vcbacked.co/company/lightship-el-segundo. Accessed July 28, 2026.
VCBacked. (2024). Lightship — Funding & Investors. Retrieved July 28, 2026, from https://www.vcbacked.co/company/lightship-el-segundo
{{cite web |title=Lightship — Funding & Investors |url=https://www.vcbacked.co/company/lightship-el-segundo |website=VCBacked |access-date=July 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated